Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular targeting with phage peptide libraries.

R Pasqualini1

  • 1La Jolla Cancer Research Center, Burnham Institute, CA 92037, USA.

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|August 3, 1999
PubMed
Summary

Researchers developed a new method to find organ and tumor-homing peptides using phage display. These peptides target specific receptors on blood vessels, improving drug delivery and reducing toxicity in cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.

The pharmacogenomics journal·2017
Same author

An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.

Cancer gene therapy·2017
Same author

Luminescent silica nanoparticles for cancer diagnosis.

Current medicinal chemistry·2013
Same author

Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity.

Cancer gene therapy·2012
Same author

A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation.

Oncogene·2008
Same author

Optical systems for in vivo molecular imaging of cancer.

Technology in cancer research & treatment·2003

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Oncology

Background:

  • Targeted drug delivery remains a significant challenge in cancer therapy.
  • Developing strategies to specifically target tumor vasculature is crucial for improving treatment efficacy and reducing side effects.

Purpose of the Study:

  • To develop an in vivo selection system for isolating organ- and tumor-homing peptides.
  • To investigate the potential of these peptides for targeted drug delivery in cancer treatment.

Main Methods:

  • Utilized a phage display peptide library for in vivo selection after intravenous administration.
  • Isolated peptides were characterized for their binding specificities to tissue-specific receptors.
  • Assessed the efficacy of peptide-targeted doxorubicin delivery in animal cancer models.

Related Experiment Videos

Main Results:

  • Successfully isolated several peptides with selective homing capabilities to different organs and tumors.
  • Identified that these peptides bind to distinct receptors upregulated on tumor angiogenic vasculature.
  • Demonstrated that targeted doxorubicin delivery using these peptides significantly decreased toxicity and enhanced therapeutic efficacy in vivo.

Conclusions:

  • The developed in vivo selection system is effective for identifying targeted delivery vectors.
  • Vascular targeting of tumors using these peptides holds promise for improved cancer therapeutics.
  • This technology can be extended for targeted delivery of various agents across multiple diseases.